UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

pH-Mediated Potentiation of Aminoglycosides Kills Bacterial Persisters and Eradicates In Vivo Biofilms

The Journal of infectious diseases, 2014-11, Vol.210 (9), p.1357-1366

2014

Volltextzugriff (PDF)

Dietary Pectin-Derived Acidic Oligosaccharides Improve the Pulmonary Bacterial Clearance of Pseudomonas aeruginosa Lung Infection in Mice by Modulating Intestinal Microbiota and Immunity

The Journal of infectious diseases, 2015-01, Vol.211 (1), p.156-165

2015

Volltextzugriff (PDF)

Pseudomonas aeruginosa : new insights into pathogenesis and host defenses

Pathogens and disease, 2013-04, Vol.67 (3), p.159-173

2013

Volltextzugriff (PDF)

High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial

Journal of antimicrobial chemotherapy, 2019-05, Vol.74 (5), p.1244-1252

2019

Volltextzugriff (PDF)

Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria

The Journal of infectious diseases, 2017-02, Vol.215 (suppl_1), p.S9-S17

2017

Volltextzugriff (PDF)

Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa

Journal of antimicrobial chemotherapy, 2018-03, Vol.73 (3), p.658-663

2018

Volltextzugriff (PDF)

New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection

Journal of antimicrobial chemotherapy, 2015-12, Vol.70 (12), p.3291-3297

2015

Volltextzugriff (PDF)

Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model

Journal of antimicrobial chemotherapy, 2012-05, Vol.67 (5), p.1198-1206

2012

Volltextzugriff (PDF)

Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa

The Journal of infectious diseases, 2019-07, Vol.220 (4), p.666-676

2019

Volltextzugriff (PDF)

Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa

Journal of antimicrobial chemotherapy, 2024-10, Vol.79 (10), p.2591-2597

2024

Volltextzugriff (PDF)

In Vivo Validation of Peptidoglycan Recycling as a Target to Disable AmpC-Mediated Resistance and Reduce Virulence Enhancing the Cell-Wall–Targeting Immunity

The Journal of infectious diseases, 2019-10, Vol.220 (11), p.1729-1737

2019

Volltextzugriff (PDF)

Clinical manifestations and treatment outcomes for patients with Pseudomonas endocarditis

Journal of antimicrobial chemotherapy, 2024-08, Vol.79 (8), p.2017-2021

2024

Volltextzugriff (PDF)

Colistin-Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of Biofilm Pseudomonas aeruginosa

The Journal of infectious diseases, 2010-11, Vol.202 (10), p.1585-1592

2010

Volltextzugriff (PDF)

A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa

Journal of antimicrobial chemotherapy, 2024-06, Vol.79 (6), p.1337

2024

Volltextzugriff (PDF)

A novel antimicrobial peptide S24 combats serious wound infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii

Journal of antimicrobial chemotherapy, 2024-08, Vol.79 (8), p.1951-1961

2024

Volltextzugriff (PDF)

Unravelling the genome of a Pseudomonas aeruginosa isolate belonging to the high-risk clone ST235 reveals an integrative conjugative element housing a blaGES-6 carbapenemase

Journal of antimicrobial chemotherapy, 2018-01, Vol.73 (1), p.77-83

2018

Volltextzugriff (PDF)

The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa Pneumonia

The Journal of infectious diseases, 2024-08, Vol.230 (2), p.309-318

2024

Volltextzugriff (PDF)

Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis

The Journal of infectious diseases, 2024-09, Vol.230 (3), p.e536-e547

2024

Volltextzugriff (PDF)

Overcoming antibiotic resistance: non-thermal plasma and antibiotics combination inhibits important pathogens

Pathogens and disease, 2024-02, Vol.82

2024

Volltextzugriff (PDF)

Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with bronchiectasis

Journal of antimicrobial chemotherapy, 2022-05, Vol.77 (6), p.1600-1610

2022

Volltextzugriff (PDF)

Evaluation of short exposure times of antimicrobial wound solutions against microbial biofilms: from in vitro to in vivo

Journal of antimicrobial chemotherapy, 2018-02, Vol.73 (2), p.494-502

2018

Volltextzugriff (PDF)

Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin

Journal of antimicrobial chemotherapy, 2019-01, Vol.74 (1), p.269-271

2019

Volltextzugriff (PDF)

Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams

Journal of antimicrobial chemotherapy, 2015-12, Vol.70 (12), p.3357-3365

2015

Volltextzugriff (PDF)

Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study

Journal of antimicrobial chemotherapy, 2021-12, Vol.77 (1), p.223-228

2021

Volltextzugriff (PDF)

Interaction of Drug- and Granulocyte-Mediated Killing of Pseudomonas aeruginosa in a Murine Pneumonia Model

The Journal of infectious diseases, 2014-10, Vol.210 (8), p.1319-1324

2014

Volltextzugriff (PDF)

1 – 25 von 678

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Journals【キャンパス外アクセス可】

Zeitschrift / SerieClinical Infectious Diseases

SpracheTürkisch

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(674)
Mit Volltextzugriff
(495)

Publikationsform

Artikel
(678)

Sprache

Englisch
(678)

Erscheinungsjahr

n.n

Thema

Science & Technology
(608)
Life Sciences & Biomedicine
(607)
Infectious Diseases
(542)
Microbiology
(530)
Humans
(521)
Pseudomonas Infections - Drug Therapy
(451)
Pharmacology & Pharmacy
(357)
Pseudomonas Aeruginosa
(300)
Female
(273)
Male
(271)
Pseudomonas Aeruginosa - Drug Effects
(266)
Biological And Medical Sciences
(264)
Medical Sciences
(261)
Microbial Sensitivity Tests
(234)
Pharmacology. Drug Treatments
(225)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(219)
Antibiotics
(211)
Anti-Bacterial Agents - Therapeutic Use
(206)
Adult
(198)
Immunology
(193)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

pH-Mediated Potentiation of Aminoglycosides Kills Bacterial Persisters and Eradicates In Vivo Biofilms

Dietary Pectin-Derived Acidic Oligosaccharides Improve the Pulmonary Bacterial Clearance of Pseudomonas aeruginosa Lung Infection in Mice by Modulating Intestinal Microbiota and Immunity

Pseudomonas aeruginosa : new insights into pathogenesis and host defenses

High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial

Interplay Between Antibiotic Resistance and Virulence During Disease Promoted by Multidrug-Resistant Bacteria

Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa

New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection

Synergistic antibacterial efficacy of early combination treatment with tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperitoneal foreign-body infection mouse model

Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa

Impact of chromosomally encoded resistance mechanisms and transferable β-lactamases on the activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against Pseudomonas aeruginosa

In Vivo Validation of Peptidoglycan Recycling as a Target to Disable AmpC-Mediated Resistance and Reduce Virulence Enhancing the Cell-Wall–Targeting Immunity

Clinical manifestations and treatment outcomes for patients with Pseudomonas endocarditis

Colistin-Tobramycin Combinations Are Superior to Monotherapy Concerning the Killing of Biofilm Pseudomonas aeruginosa

A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa

A novel antimicrobial peptide S24 combats serious wound infections caused by Pseudomonas aeruginosa and Acinetobacter baumannii

Unravelling the genome of a Pseudomonas aeruginosa isolate belonging to the high-risk clone ST235 reveals an integrative conjugative element housing a blaGES-6 carbapenemase

The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa Pneumonia

Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis

Overcoming antibiotic resistance: non-thermal plasma and antibiotics combination inhibits important pathogens

Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with bronchiectasis

Evaluation of short exposure times of antimicrobial wound solutions against microbial biofilms: from in vitro to in vivo

Mechanisms of high-level ceftolozane/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin

Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams

Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study

Interaction of Drug- and Granulocyte-Mediated Killing of Pseudomonas aeruginosa in a Murine Pneumonia Model

Aktive Filter

Suchergebnisse filtern